ACTRN12619000441112招募中未知
iving Well after Breast Cancer: a pilot study exploring physiological differences between women with premenopausal breast cancer, and postmenopausal women with breast cancer, and their response to a partial meal replacement dietary intervention
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- Female
入选标准
- •Women with premenopausal breast cancer
- •-Diagnosed with invasive breast cancer (stage I-IIIc)
- •-Oestrogen receptor positive disease (ER+)
- •-Premenopausal at diagnosis
- •-BMI greater than or equal to 27kg/m2
- •-Finished primary treatment (i.e. surgery, chemotherapy and/or radiotherapy)
- •-Received chemotherapy treatment for breast cancer
- •Women with postmenopausal breast cancer
- •Diagnosed with invasive breast cancer (stage I-IIIc)
- •Oestrogen receptor positive disease (ER+)
- •Postmenopausal at diagnosis
- •BMI greater than or equal to 27kg/m2
- •Finished primary treatment (i.e. surgery, chemotherapy and/or radiotherapy)
- •Aged between 58-63 years at diagnosis (under 65 years at study enrolment)
- •Received chemotherapy treatment for breast cancer
排除标准
- •Women with premenopausal breast cancer
- •-Ductal carcinoma in situ (DCIS; stage 0), distant metastases (stage IV) or triple negative breast cancer (TNBC)
- •-Diagnosed more than two years ago
- •-Currently pregnant or plan to conceive during the study period
- •-Contraindication to participating in an unsupervised program - active heart disease, impaired mobility, Insulin dependent diabetes, low liver/kidney function (from blood test)
- •-Currently taking or planning to start taking weight loss medications
- •-Insufficient English to complete assessments and participate in the intervention
- •-Unable to travel to Brisbane to complete study assessments
- •-Reporting depression/anxiety as a current significant problem that would interfere with study participation.
- •-Allergy or intolerance to soy, dairy or lactose
- •Women with postmenopausal breast cancer
- •Ductal carcinoma in situ (DCIS; stage 0), distant metastases (stage IV) or triple negative breast cancer (TNBC)
- •Diagnosed more than two years ago
- •Currently pregnant or plan to conceive during the study period
- •Contraindication to participating in an unsupervised program - active heart disease, impaired mobility, Insulin dependent diabetes, low liver/kidney function (from blood test)
- •Currently taking or planning to start taking weight loss medications
- •Insufficient English to complete assessments and participate in the intervention
- •Unable to travel to Brisbane to complete study assessments
- •Reporting depression/anxiety as a current significant problem that would interfere with study participation.
- •Allergy or intolerance to soy, dairy or lactose
研究者
相似试验
已完成
不适用
Breast cancer aftercare and follow up and programQuality of life and treatment consequences after breast cancerC50Malignant neoplasm of breastDRKS00028840niversitätsklinikum Würzburg933
进行中（未招募）
不适用
Long Term Follow-Up in Patients With Stage 0-IIIC Breast CancerBreast CancerNCT04661982City of Hope Medical Center500
尚未招募
不适用
iving well with secondary breast cancer - the clinical outcomes and patient perceptions of a combined exercise and educational support group.Cancer - Breastmetastatic breast cancerACTRN12621001174875Cabrini Health40
已完成
不适用
Breast Cancer in Remission: A Randomised Trial of Follow-UpBreastBreast cancerCancerISRCTN18466386Department of Health
尚未招募
Unknown
A Study on Quality of Life assessment in Patients with Breast CancerCTRI/2024/06/068845ational Institute Of Siddha